Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Synergistic effects of a cremophor EL drug delivery system and its U0126 cargo in an ex vivo model.

Christensen ST, Grell AS, Johansson SE, Andersson CM, Edvinsson L, Haanes KA.

Drug Deliv. 2019 Dec;26(1):680-688. doi: 10.1080/10717544.2019.1636421.

2.

Automated VSS-based Burn Scar Assessment using Combined Texture and Color Features of Digital Images in Error-Correcting Output Coding.

Pham TD, Karlsson M, Andersson CM, Mirdell R, Sjoberg F.

Sci Rep. 2017 Dec 1;7(1):16744. doi: 10.1038/s41598-017-16914-0.

3.

The thyroid hormone mimetic compound KB2115 lowers plasma LDL cholesterol and stimulates bile acid synthesis without cardiac effects in humans.

Berkenstam A, Kristensen J, Mellström K, Carlsson B, Malm J, Rehnmark S, Garg N, Andersson CM, Rudling M, Sjöberg F, Angelin B, Baxter JD.

Proc Natl Acad Sci U S A. 2008 Jan 15;105(2):663-7. Epub 2007 Dec 26.

4.

Local media monitoring in process evaluation. Experiences from the Stockholm Diabetes Prevention Programme.

Andersson CM, Bjärås G, Tillgren P, Ostenson CG.

J Health Commun. 2007 Apr-May;12(3):269-83.

PMID:
17497380
5.

Pharmacological and behavioral profile of N-(4-fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide (2R,3R)-dihydroxybutanedioate (2:1) (ACP-103), a novel 5-hydroxytryptamine(2A) receptor inverse agonist.

Vanover KE, Weiner DM, Makhay M, Veinbergs I, Gardell LR, Lameh J, Del Tredici AL, Piu F, Schiffer HH, Ott TR, Burstein ES, Uldam AK, Thygesen MB, Schlienger N, Andersson CM, Son TY, Harvey SC, Powell SB, Geyer MA, Tolf BR, Brann MR, Davis RE.

J Pharmacol Exp Ther. 2006 May;317(2):910-8. Epub 2006 Feb 9.

PMID:
16469866
6.

A longitudinal assessment of inter-sectoral participation in a community-based diabetes prevention programme.

Andersson CM, Bjärås G, Tillgren P, Ostenson CG.

Soc Sci Med. 2005 Dec;61(11):2407-22. Epub 2005 Jun 13.

PMID:
15951085
7.

Pharmacological characterization of AC-90179 [2-(4-methoxyphenyl)-N-(4-methyl-benzyl)-N-(1-methyl-piperidin-4-yl)-acetamide hydrochloride]: a selective serotonin 2A receptor inverse agonist.

Vanover KE, Harvey SC, Son T, Bradley SR, Kold H, Makhay M, Veinbergs I, Spalding TA, Weiner DM, Andersson CM, Tolf BR, Brann MR, Hacksell U, Davis RE.

J Pharmacol Exp Ther. 2004 Sep;310(3):943-51. Epub 2004 Apr 21.

PMID:
15102927
8.

Health promotion activities in annual reports of local governments: 'Health for All' targets as a tool for content analysis.

Andersson CM, Bjärås GE, Tillgren P, Ostenson CG.

Eur J Public Health. 2003 Sep;13(3):235-9.

PMID:
14533726
9.

A stage model for assessing a community-based diabetes prevention program in Sweden.

Andersson CM, Bjärås GE, Ostenson CG.

Health Promot Int. 2002 Dec;17(4):317-27.

PMID:
12406920
10.

5-hydroxytryptamine2A receptor inverse agonists as antipsychotics.

Weiner DM, Burstein ES, Nash N, Croston GE, Currier EA, Vanover KE, Harvey SC, Donohue E, Hansen HC, Andersson CM, Spalding TA, Gibson DF, Krebs-Thomson K, Powell SB, Geyer MA, Hacksell U, Brann MR.

J Pharmacol Exp Ther. 2001 Oct;299(1):268-76.

PMID:
11561089
11.

Multistep solution-phase parallel synthesis of spiperone analogues.

Hansen HC, Olsson R, Croston G, Andersson CM.

Bioorg Med Chem Lett. 2000 Nov 6;10(21):2435-9.

PMID:
11078195
12.

Iron-mediated synthetic routes to unsymmetrically substituted, sterically congested benzophenones

Storm JP, Andersson CM.

J Org Chem. 2000 Aug 25;65(17):5264-74.

PMID:
10993355
13.
14.

Higher order iminodiacetic acid libraries for probing protein-protein interactions.

Boger DL, Goldberg J, Jiang W, Chai W, Ducray P, Lee JK, Ozer RS, Andersson CM.

Bioorg Med Chem. 1998 Aug;6(8):1347-78.

PMID:
9784874
15.

Antioxidative properties of organotellurium compounds in cell systems.

Wieslander E, Engman L, Svensjö E, Erlansson M, Johansson U, Linden M, Andersson CM, Brattsand R.

Biochem Pharmacol. 1998 Mar 1;55(5):573-84.

PMID:
9515568
16.

Organotellurium compounds as efficient retarders of lipid peroxidation in methanol.

Engman L, Persson J, Vessman K, Ekström M, Berglund M, Andersson CM.

Free Radic Biol Med. 1995 Oct;19(4):441-52.

PMID:
7590393
17.

Synthesis, antioxidant properties, biological activity and molecular modelling of a series of chalcogen analogues of the 5-lipoxygenase inhibitor DuP 654.

Engman L, Stern D, Frisell H, Vessman K, Berglund M, Ek B, Andersson CM.

Bioorg Med Chem. 1995 Sep;3(9):1255-62.

PMID:
8564418
18.

Diaryl tellurides as inhibitors of lipid peroxidation in biological and chemical systems.

Andersson CM, Brattsand R, Hallberg A, Engman L, Persson J, Moldéus P, Cotgreave I.

Free Radic Res. 1994 Jun;20(6):401-10.

PMID:
8081455
19.

Antioxidant activity of some diarylselenides in biological systems.

Andersson CM, Hallberg A, Linden M, Brattsand R, Moldéus P, Cotgreave I.

Free Radic Biol Med. 1994 Jan;16(1):17-28.

PMID:
8299991
20.

Alpha-(phenylselenenyl)acetophenone derivatives with glutathione peroxidase-like activity. A comparison with ebselen.

Cotgreave IA, Moldéus P, Brattsand R, Hallberg A, Andersson CM, Engman L.

Biochem Pharmacol. 1992 Feb 18;43(4):793-802.

PMID:
1540234

Supplemental Content

Loading ...
Support Center